Profile
David H.
Deaton worked as the Chief Medical Officer at Endologix LLC from 2013 to 2016.
Prior to that, he was an Associate Professor at Georgetown University and served as the Chief of the Vascular & Endovascular Surgery Division at Georgetown University Hospital.
Deaton received his undergraduate degree from Haverford College and his doctorate from Duke University School of Medicine.
Former positions of David H. Deaton
| Companies | Position | End |
|---|---|---|
| ENDOLOGIX, INC. | Chief Tech/Sci/R&D Officer | 01/12/2016 |
| Georgetown University | Corporate Officer/Principal | - |
Georgetown University Hospital
 Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Training of David H. Deaton
| Haverford College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Georgetown University Hospital
Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Distribution Services |
- Stock Market
- Insiders
- David H. Deaton
